Source: Annual Congress 2009 - Pleural and parenchymal diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D. Ionita, C. Cilt, C. Tudose, D. Marta, D. Bumbacea, I. Strambu, A. Macri, C. Toma, I. Balcu, I. P. Stoicescu (Bucharest, Romania). Sarcoidosis onset and clinical data in a large patient series. Eur Respir J 2009; 34: Suppl. 53, 3532

Member's Comments

No comment yet.

Related content which might interest you: Sarcoidosis – an initial radiological and clinical presentation in various ethnic groups Source: Eur Respir J 2007; 30: Suppl. 51, 115s Year: 2007 PROOF-registry: A prospective observational registry to describe the disease course and outcomes of IPF patients in a real-world clinical setting- An interim report Source: International Congress 2015 – IPF: clinical aspects Year: 2015 Clinical features of autoimmune pulmonary alveolar proteinosis from a large international patient cohort: baseline data from the IMPALA trial Source: International Congress 2019 – Rare and ultra-rare diseases and the lungs: updates and new perspectives Year: 2019 The comparison of sarcoidosis patients with benign and recurrent clinical course of the disease Source: Eur Respir J 2005; 26: Suppl. 49, 331s Year: 2005 Thymic neoplasms: clinical presentation, diagnosis and management - A single institution experience Source: International Congress 2017 – Pleural and mediastinal malignancies Year: 2017 Clinical features of sarcoidosis patients with erythema nodosum and predictors of the course at onset: a single center experience from Turkey Source: Eur Respir J 2007; 30: Suppl. 51, 84s Year: 2007 Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases Source: Eur Respir Rev, 27 (150) 180076; 10.1183/16000617.0076-2018 Year: 2018 Clinical presentation in CF patients with large deletions Source: Virtual Congress 2020 – Cystic fibrosis Year: 2020 A comparison of the clinical profile of Sarcoidosis and Mediastinal TB: A prospective cohort study in a TB endemic population Source: Virtual Congress 2020 – Clinical issues in granulomatous lung diseases Year: 2020 Sinonasal involvement is a severe manifestation of sarcoidosis: a case-control study of 20 patients Source: Eur Respir J 2002; 20: Suppl. 38, 435s Year: 2002 Interstitial pneumonia with autoimmune features associated with myositis autoantibodies: clinical characteristics from a multicenter Latin-American cohort. Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside Year: 2019 Safety of Mepolizumab for severe eosinophilic refractory asthma in a single-center cohort including a patient with echinococcus hepatic cyst and a patient with lung cancer . A single center one year follow up. Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma Year: 2019 Clinical management of patients newly diagnosed with COPD through targeted case finding and routine care: a longitudinal analysis of the TargetCOPD trial Source: International Congress 2018 – Integrating pharmacological and non-pharmacological management in COPD: are we there yet? Year: 2018 Sarcoidosis: imagiological findings and their impact on the disease outcome Source: International Congress 2018 – Granulomatous disorders: heterogeneous diseases with variable management Year: 2018 Sarcoidosis and malignancy. Retrospective study of 6 clinical cases and literature review Source: Annual Congress 2010 - Management of sarcoidosis and lung manifestations of systemic diseases Year: 2010 Analysis of multicentric Castleman’s disease with pulmonary involvement: A single center study Source: International Congress 2019 – Innovative approaches for management and treatment of rare diffuse parenchymal lung diseases Year: 2019 Interstitial pneumonia with autoimmune features: applying novel diagnostic criteria to an existing patient cohort. Source: International Congress 2017 – Novel and old entities Year: 2017 PROOF: A prospective observational registry to describe the disease course and outcomes of idiopathic pulmonary fibrosis patients in a real-world clinical setting in Belgium and Luxembourg: Exposure in the interim report of 175 IPF patients Source: International Congress 2016 – IPF clinical Year: 2016 Scottish pulmonary sarcoidosis – an exploratory analysis of prevalence, presentation and clinical data in nearly 200 patients Source: Annual Congress 2009 - Sarcoidosis in review Year: 2009 The pattern of disease and diagnostic yields in a cohort of patients with sarcoidosis in a regional centre Source: Eur Respir J 2007; 30: Suppl. 51, 116s Year: 2007